Single-Use Mammalian Cell Culture Facility - Vial to Vial
Challenge from the Client
Our challenge was to design a biologics manufacturing launch facility within an existing shell & office building. Not only were we tasked with bringing new site utilities to the building, we also were limited by a low roof height, lightweight roof structure, and an existing building shape that was not conducive to both material and personnel movements.
Our Approach & Solution
This project codified the benefits of early conceptual design exploration. IPS analyzed the client's priorities, explored different building arrangements and through a series of high level reviews and designed a facility that met the capacity requirements and allowed for future expansion. Because the existing facility was undersized the team worked together to locate some utilities outside the building footprint and prioritized others to remain indoors.
The Results
This became a successful design-bid-build project where the construction moved along smoothly and the facility was up and running on schedule and budget. Midway through the project the client introduced a drug product requirement which included a small-scale isolated filling line which was included into the facility during the construction of the drug substance phase. Because of the favorable outcome, this client became a repeat-customer, one that we continue to work with on improving the campus and this facility.
Related Molecules
Mobile Modular Vaccine Facility
Read MoreDeliver a modular vaccine facility capable of being relocated anywhere in the world with minimal host facility requirements.
Delivering a New Building with Two Project Teams
Read MoreProvided a client and building tenant with construction management services for the interior fit-out of a new 50,000sf pharmaceutical testing facility while a separate vendor constructs the core & shell for the landlord.
Clinical Aseptic Spray Drying Facility Project
Read MoreIPS utilized the Inceptioneering process and expertise in aseptic spray drying technology for manufacturing APIs for formulation and filling.
Replacement Powder Mill for Pharmaceutical Client
Read MoreAfter a previous remediation attempts from other consultants failed, IPS was brought in to solve our client’s excess temperature problems in their new milling equipment.
Potent Processing on Antiquated Equipment
Read MoreIPS experts provided the latest technical solutions to retrofit a facility to improve manufacturing processes.
Modular Design, Construction and Installation of QC Labs
Read MoreA copy/paste modular build from the UK to Spain that overcame hurdles from the UK’s decision to leave the European Union.
Design of an Award-Winning, Fully Integrated Dual Sterile Filtration Unit, With In-situ Integrity Testing and Elimination of Contamination Routes
Read MoreIPS experts designed a filter skid system to eliminate contamination risks related to manual operations.
Innovative Commercial-Scale Parenteral Fill/Finish Facility
Read MoreUsing Facility of the Future design principles, IPS designed a world-class, flexible, 490,000sf. facility.
3D Modelling and Laser Scanning
Read More3D laser scanning used to coordinate and design a new PTW generation skid and pipework connections within an existing operating facility.
Next Generation Propellant Technology for Pharmaceutical MDI Applications
Read MoreIPS provided technical and site master planning expertise enabling new commercial opportunities within the MDI market sector.
Antibody Drug Conjugation Commercial Manufacturing
Read MoreApplied first class design tools and industry specific experiences to develop a greenfield site for commercial ADC manufacturing.
Mammalian Cell Culture to COVID-19 Vaccine Adjuvant in 3 weeks
Read MoreSoon after the COVID-19 outbreak, our client's direction shifted quickly from a mammalian cell culture facility to a COVID-19 vaccine adjuvant production facility.
Annex 1 - The Brave New World of Aseptic Regulatory Compliance
Read MoreAfter six years in review, the final emergence of Annex 1 in August 2022 has either been a consolidation of accepted practice and wisdom, or a rude awakening for many!
Gene Therapy Facility
Read MoreOur client needed an efficient design for their gene biologics plant within an existing building with limited space for air handlers and mechanical equipment.
Large-Scale Bulk Manufacturing Facility
Read MoreIPS built a new greenfield facility in Ireland for bulk biologics manufacturing with single-use technology under an extremely aggressive timeline.
Fast-Track Project Delivery Model
Read MoreA vaccine manufacturer and distributor needed IPS’ expertise to meet an aggressive timeline for expansion of their production facility.
Detailed Process Piping
Read MoreSupporting a client’s dynamic business requirements to produce a near-fabrication-level model to reduce schedule time.
Water For Injection (WFI) Generation System Design for a Global CMO Biotechnology Facility for the Manufacture of mAb/Recombinant Protein
Read MoreBiotech CMO client needed an n+1 redundant system to handle increased WFI demand, while reducing operating costs.
Commercial Manufacturing of Autologous Muscle Derived Cell (AMDC) products
Read MoreApplying industry-leading knowledge and expertise to support CGMP-compliant manufacturing process scale-up.
Clinical Phage Production - Design/Build/Qualify
Read MoreA start-up biotech company needed to generate phase 1 and phase 2 clinical material for a phage-based therapy on an aggressive timeline and tight budget.
Largest Single-use Based mAb Facility in the World
Read MoreOur CMO client wanted to do something radically different by creating a multiproduct, multiscale mAb facility that could flex upstream capacity in 2000L intervals.
